Trastuzumab — Dosing in CKD & Dialysis

Trastuzumab (Monoclonal Antibody): renal dosing adjustments, dialyzability (Not studied in the label (pharmacokinetics in end-stage renal disease with or without hemodialysis are unknown; Herceptin label 12.3); humanized IgG1 monoclonal antibody of about 148 kDa (Herceptin Hylecta label 11); in one

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.